Nanogene Diagnostics

Rasing 1.5 to 2M for A private Pathology Lab in Dubai providing Kidney and Genetic Oncology Testing

Facebook Twitter LinkedIn

Full service pathology lab with a focus on renal pathology and cancer genetics providing services in United Arab Emeritus (Dubai and GCC region).  

I would like to introduce my company, NanoGene Diagnostics, a full-service pathology lab provides diagnostic services to hospitals in Dubai, UAE, aiming to bridge the gap in local capabilities. We specialize in certain pathology tests that are not available in the UAE, and samples have to be sent to the US or Europe for evaluation, resulting in an average turnaround time of 15 to 60 days. Our goal is to deliver results within 5 days in most cases. NanoGene Dubai is poised to become the market leader in kidney and genetic oncology diagnosis in The GCC. Our unparalleled experience and background in the field set us apart from all competitors. National Reference Lab (NRL) is the largest local competitor, they have been sending their tests to Cleveland Clinic in Ohio for review. 

The lab will be implemented in three phases:

Phase 1: Renal Pathology Services (3-4 months) - This phase includes digital consultation pathology with a panel of American Board-Certified Pathologists. All Renal Pathology cases in the UAE will be processed and reviewed in Dubai.   

Phase 2: Genetic Oncology Testing (5 to 6 m) - This phase will encompass all genetic testing needed for various types of cancers, including breast, lung, intestinal, leukemia, and lymphoma, etc. It is the most challenging and exciting phase of the project. This phase will take approximately one to 2 years to fully implement.

Phase 3: Leukemia & Lymphoma Services (6 – 18 m) - This phase will cover all pathological testing required for the diagnosis and management of patients with various blood cancer. Currently, Sheikh Shakhboot (SCMS) and Cleveland Clinic Abu Dhabi are the region's largest leukemia lymphoma centers, but they only offer basic diagnostic services and lack genetic and chromosome testing. They send genetic oncology workup to Cleveland and Mayo Clinics. 

The complete execution of the three phases will require a total timeframe of 1 to 2 years.

The entire project will necessitate an estimated investment of approximately 3.0 million USD. The founder is personally investing in the lab's establishment and funding phase 1 of the project. At present, we are seeking $1.5 to $2M in two rounds in the next 12 months, for a 20% convertible note in return. We are open to tying the term sheet with a productivity matrix to ensure transparency and mutual growth.

Don’t forget to check our website: www.nanogene.com

Please feel free to reach out if you have any questions.

Ready to Ask For Funding for your company?

Post a Funding Request

Nanogene Diagnostics is no longer seeking funding.